Fast-Track Cardiovascular Assessment for Suspicion of Cardiovascular Events on Immunecheckpoint Inhibitors
Launched by INSTITUT MUTUALISTE MONTSOURIS · Mar 23, 2023
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how immune checkpoint inhibitors, which are treatments used for certain cancers, can sometimes lead to heart-related problems. The researchers want to understand these potential heart issues better by observing patients who are suspected of having cardiovascular complications while receiving these treatments. This includes conditions like heart failure, inflammation of the heart, or abnormal heart rhythms.
If you or a loved one has been referred to the cardio-oncology unit because of concerns about heart complications from immune checkpoint inhibitors, you may be eligible to participate in this study. There are no specific exclusions, so if you qualify and decide to join, you can expect to undergo various tests and evaluations. The information gathered from this study aims to improve understanding and management of heart issues related to cancer treatments, ultimately helping future patients receive safer, more effective care.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • all patient referred to the cardio oncology unit for suspected immune related cardiovascular complication on immune checkpoint inhibitors
- Exclusion Criteria:
- • none
About Institut Mutualiste Montsouris
Institut Mutualiste Montsouris is a renowned healthcare institution based in Paris, France, dedicated to advancing medical research and improving patient care through innovative clinical trials. As a key sponsor of clinical studies, the organization focuses on a wide range of therapeutic areas, aiming to enhance treatment outcomes and contribute to the scientific community's understanding of various health conditions. With a commitment to ethical standards and patient safety, Institut Mutualiste Montsouris collaborates with multidisciplinary teams of healthcare professionals and researchers to foster excellence in clinical research and deliver high-quality healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Paris, , France
Patients applied
Trial Officials
Mariana Mirabel, MD, PhD
Principal Investigator
Institut Mutualiste Montsouris
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials